Abstract:Background and Objectives: This study aimed to develop an embolic agent with short-term embolic effects using cilastatin as the basic material. Materials and Methods: The particle size distribution of 25 mg cilastatin-based short-term embolic agents was evaluated microscopically under three different mixing conditions. A total of thirty-six healthy male Sprague Dawley rats were divided into four groups. Each group of six rats was injected once into the tail artery with 0.4 mL each of (A) Cilastatin + D-Mannitol Mixture, (B) Iohexol, (C) Prepenem, and (D) embolization promoter (EGgel). Results: A visual inspection of the tail appearance of rats in each group was performed at 0, 3, 7, 15, and 21 days. At weeks 1 and 3, three rats per group were euthanized, and histopathological analyses were performed on the specimens obtained from each group. No significant differences were observed on day 7, but mild inflammation was observed in Group (D) on day 15. Histopathological inflammation scoring of tail central artery embolization was performed using a six-point scale (from 0 = absent to 5 = marked inflammation). Three groups were formed consisting of six male New Zealand white rabbits each: control, positive control, and test groups. The control group received an Iohexol injection (rabbits: 0.8 mL). The positive control and experimental groups were injected with prepenem and cilastatin/D-mannitol compound, respectively (0.8 mL), and vascular angiography was performed. The order of occlusion progression after embolization was as follows: test group, positive control group, and control group. Conclusions: We developed a cilastatin/D-mannitol compound that exhibits characteristics of short-term embolization by utilizing the pharmacokinetic properties of cilastatin and the crystalline material D-mannitol. We evaluated its particle size distribution microscopically, conducted histopathological evaluation including inflammation via animal experiments, and assessed the embolization effect.

Experimental Research of a New Liquid Embolic Agent-Bcd Mixture

Research of novel biocompatible radiopaque microcapsules for arterial embolization

Iodinated Cyanoacrylate‐based Novel Liquid Embolic Compositions with Inherent Radiopacity for Endovascular Embolization

Development of a Short-Term Embolic Agent Based on Cilastatin for Articular Microvessels

Biocompatibility and Effectiveness Evaluation of a New Hemostatic Embolization Agent: Thrombin Loaded Alginate Calcium Microsphere

Experimental study on embolization of rabbit renal artery with gelatin sponge microspheres

A new liquid agent for endovascular embolization: initial clinical experience

ASSA14-12-07 in Vitroandin Vivobiocompatibility Evoluation of New Vascular Embolization Agent:

Phase Transitional Bismuth‐Based Metals Enabled Rapid Embolotherapy, Hyperthermia and Biomedical Imaging

Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease the BIO-RISE CHINA Study

[Preparation and Investigation of MRI-traceable Eudragit-E Liquid Embolic Agent].

Construction of an Injectable Composite Double-Network Hydrogel As a Liquid Embolic Agent.

Temperature-sensitive poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel as an embolic agent: distribution, durability of vascular occlusion, and inflammatory reactions in the renal artery of rabbits

Experimental Study of Renal Artery Embolization with Alginate Microspheres

Liquid embolic agents for interventional embolization

A Novel Coacervate Embolic Agent for Tumor Chemoembolization

Development of biocompatible silicone hyrogels with high resistance to protein adsorption and bacterial adhesion.

Comparison of Pharmacokinetics and Drug Release in Tissues after Transarterial Chemoembolization with Doxorubicin Using Diverse Lipiodol Emulsions and CalliSpheres Beads in Rabbit Livers

Pharmacokinetics of Doxorubicin Alginate Microspheres and Evaluation of Its Hepatic Arterial Embolization in Vivo

[Preparation and Evaluation of Radiopaque Microspheres].

Preparation and Evaluation of Biocompatible Long-Term Radiopaque Microspheres Based on Polyvinyl Alcohol and Lipiodol for Embolization